The phase 2b SOLSTICE trial evaluated the efficacy, safety, and tolerability of elecoglipron in adults with type 2 diabetes and inadequate glycemic management (A1C ≥7% and ≤10.5%). The randomized, ...
Findings highlight potential to expand oral GLP-1 RA treatment options for patients with type 2 diabetes and obesity NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Findings from two phase 2 studies ...
As we age, we notice many changes in our bodies. Many obvious changes take place in our skin. Do you have wrinkles and facial lines that you want to get rid of without surgery? Well, the vampire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results